Previous literature has investigated numerous therapeutic and prognostic biomarkers that are involved in the molecular mechanism of urinary tract tumors like VEGF, CXCR3 in renal cell carcinoma, PSA in prostate cancer, and other tumors such as IL-17 in CLL (6-9). Here, VEGFA is linked to renal cell carcinoma.